These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 7912669)

  • 21. [New directions in the hypotensive therapy of open-angle glaucoma (experimental and clinical research)].
    Bunin AIa; Ermakov VN; Filina AA
    Vestn Oftalmol; 1993; 109(1):3-6. PubMed ID: 8100372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraocular pressure elevation within the first 24 hours after cataract surgery in patients with glaucoma or exfoliation syndrome.
    Levkovitch-Verbin H; Habot-Wilner Z; Burla N; Melamed S; Goldenfeld M; Bar-Sela SM; Sachs D
    Ophthalmology; 2008 Jan; 115(1):104-8. PubMed ID: 17561259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Initial experience with the beta-blocker befunolol in the treatment of open-angle glaucoma in Europe].
    Merté HJ; Stryz JR
    Klin Monbl Augenheilkd; 1984 Jan; 184(1):55-8. PubMed ID: 6142975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Long-term treatment of wide-angle glaucoma with the beta blocker levomoprolol: therapeutic effectiveness without side effects].
    Pecori-Giraldi J; Virno M; Ralli R; Planner-Terzaghi A
    Fortschr Ophthalmol; 1986; 83(5):564-6. PubMed ID: 2878862
    [No Abstract]   [Full Text] [Related]  

  • 25. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Manni G; Denis P; Chew P; Sharpe ED; Orengo-Nania S; Coote MA; Laganovska G; Volksone L; Zeyen T; Filatori I; James J; Aung T
    J Glaucoma; 2009; 18(4):293-300. PubMed ID: 19365194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost.
    Miura K; Ito K; Okawa C; Sugimoto K; Matsunaga K; Uji Y
    J Glaucoma; 2008; 17(3):233-7. PubMed ID: 18414111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analytic review of bimatoprost, latanoprost and travoprost in primary open angle glaucoma.
    Holmstrom S; Buchholz P; Walt J; Wickstrøm J; Aagren M
    Curr Med Res Opin; 2005 Nov; 21(11):1875-83. PubMed ID: 16307709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melatonin and its analog 5-methoxycarbonylamino-N-acetyltryptamine potentiate adrenergic receptor-mediated ocular hypotensive effects in rabbits: significance for combination therapy in glaucoma.
    Crooke A; Huete-Toral F; Martínez-Águila A; Martín-Gil A; Pintor J
    J Pharmacol Exp Ther; 2013 Jul; 346(1):138-45. PubMed ID: 23591996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Timolol maleate: side effects on healthy nonglaucomatous volunteers.
    Davidson J; Ribak J; Eckstein D; Barishak R
    Aviat Space Environ Med; 1983 Apr; 54(4):360-2. PubMed ID: 6133515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The use of prostaglandin compounds in treating glaucoma].
    Apostol S; Gafencu O; Carstocea B; Selaru D; Filip M; Cocu FG
    Oftalmologia; 1995; 39(3):214-20. PubMed ID: 7654674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mode of action, clinical profile and significance of beta-blockers in antiglaucoma therapy].
    Schlote T
    Klin Monbl Augenheilkd; 2013 Feb; 230(2):120-6. PubMed ID: 23430677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Standards of care when diagnosing or treating the glaucomas.
    Classé JG
    Optom Clin; 1991; 1(1):193-204. PubMed ID: 1799818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical evaluation of the hypotensive effectiveness of Betoptic preparation].
    Erichev VP; Abdulkadyrova MD; Kalinina OM; Shmyreva VF; Polutornov AL; Egorov EA; Shmeleva IA
    Vestn Oftalmol; 1991; 107(6):8-11. PubMed ID: 1781135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of glaucoma with beta receptor blockers].
    Demmler N
    Fortschr Med; 1980 Jun; 98(23):880-5. PubMed ID: 6106627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Additional experience with the beta blocker befunolol (Glaukonex) in open-angle glaucoma over a period of 1 year].
    Merté HJ; Stryz JR
    Klin Monbl Augenheilkd; 1984 Apr; 184(4):316-7. PubMed ID: 6144813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of chronic glaucoma].
    Tuovinen E
    Duodecim; 1986; 102(18):1278-83. PubMed ID: 2876876
    [No Abstract]   [Full Text] [Related]  

  • 37. The "usefulness" product: concern for cupping, control, and compliance.
    Worthen DM
    Ann Ophthalmol; 1978 Oct; 10(10):1393-5. PubMed ID: 31127
    [No Abstract]   [Full Text] [Related]  

  • 38. [Long-term treatment of glaucoma with propranolol ophthalmic solution (author's transl)].
    Merté HJ; Merkle W
    Klin Monbl Augenheilkd; 1980 Oct; 177(4):437-42. PubMed ID: 7253492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ocular safety of propiverine hydrochloride in elderly patients with primary open- and narrow-angle glaucoma
.
    Gatchev E; Petkova N; Braeter M; de Mey C
    Int J Clin Pharmacol Ther; 2016 Dec; 54(12):977-986. PubMed ID: 27668698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pressure compliance test of the optic nerve head: influence of different antiglaucoma drugs.
    Pillunat LE; Stodtmeister R
    Surv Ophthalmol; 1989 Apr; 33 Suppl():465-6; discussion 471-2. PubMed ID: 2568699
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.